J&J Said to Make Takeover Approach for Actelion

Bloomberg Video

Nov.25 -- Johnson & Johnson has approached Actelion about a potential takeover of the $17 billion Swiss drugmaker as the U.S. health-care giant works to expand its pharmaceutical lineup, people familiar with the matter said. Bloomberg Intelligence's Sam Fazeli has more on "Bloomberg Daybreak: Americas."